Zentrum fuer klinische Forschung Allgaeu Oberschwaben

Wangen 88239

1 studies enrolling now · 2 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Obesity, Overweight

Studies at this site

• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity — Recruiting now
• Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight — Running, not enrolling